TSO3

company

About

TSO3 develops innovative low temperature sterile reprocessing solutions for medical devices.

  • Çan,Canakkale,Turkey
  • 51 - 100

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$20M
Industries
Health Care,Manufacturing,Medical,Medical Device
Founded date
Jan 1, 1998
Number Of Employee
51 - 100
Operating Status
Active
Stock Symbol
tsx:TOS
Legal Name
TSO3 Inc.

TSO3 develops innovative low temperature sterile reprocessing solutions for medical devices.

Through superior and innovative low-temperature sterile reprocessing solutions for medical devices, we offer sterility and economic efficiency. This means better and more accessible medical care.Founded in 1998, TSO3 originally developed a unique sterilization process based on only ozone as the sterilizing agent. It offered major savings over competing low-temperature sterilization methods, greater safety for both users and patients, and was considered a “green” technology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$20.12M
TSO3 has raised a total of $20.12M in funding over 2 rounds. Their latest funding was raised on Aug 1, 2018 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 1, 2018 Post-IPO Debt $20M Detail
Mar 10, 2010 Post-IPO Equity $120K Detail
Oct 12, 2001 IPO Detail

Employee Profiles

Number of Employee Profiles
3
TSO3 has 3 current employee profiles, including Board member Jean Lamarre
Board member
Executive
Executive